People

You are here

Learn about the people that are part of the Ontario Neurodegenerative Disease Research Initiative (ONDRI) team.

Executive Commitee

  • University Health Network

    Dr. Anthony Lang’s current appointments include Director, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital; Director in Division of Neurology, University of Toronto; Lily Safra Chair in Movement Disorders, University Health Network; and Jack Clark Chair, University of Toronto Centre for Research in Neurodegenerative Disease (CRND).

    He trained in internal medicine and neurology at the University of Toronto and completed postgraduate training in movement disorders at Kings College Hospital and the Institute of Psychiatry, England. His research includes clinical studies of poorly recognized neurological disorders, clinical trials of new therapeutic modalities and collaborative basic and clinical studies involving molecular biology, neurophysiology, neuropsychology, and imaging.

    Anthony Lang Photo
  • University Health Network

    Dr. Barry Greenberg is the Director of Strategy for Toronto Dementia Research Alliance and Director, Neuroscience Drug Discovery and Development, University Health Network. He obtained his PhD in genetics from the University of North Carolina. He’s been directly involved in Alzheimer’s disease research and drug discovery since 1985.

    Barry Greenberg Photo
  • Ottawa Hospital

    Dr. David Grimes is the Associate Scientist, Neuroscience Program, Ottawa Hospital Research Institute; Chair and Chief, Neurology/Medicine, University of Ottawa; Associate Professor, Neurology/Medicine, University of Ottawa; Director, Parkinson's Disease and Movement Disorders Clinic, Ottawa Hospital; and Co-Director, Parkinson Research Consortium, University of Ottawa.

    He obtained his MD and completed his residency in neurology at the University of Ottawa. His major clinical interests are in the diagnosis and treatment of a wide variety of movement disorders with an emphasis on Parkinson's disease and dystonia. His research focus is in movement disorders with a focus on Parkinson's disease.

    David Grimes Photo
  • Western University

    Dr. Michael J. Strong is Dean of the Schulich School of Medicine & Dentistry and Distinguished University Professor, Western University and Scientist, Robarts Research Institute. He served from 2000 to 2010 as the Chief of Neurology and Co-chair of the Department of Clinical Neurological Sciences, London Health Sciences Centre and Western University. He also served as Co-chair of the Canadian Amyotrophic Lateral Sclerosis (ALS) Research Consortium and is a former member of the Board of Directors of the ALS Society of Canada.

    He undertook his undergraduate training in biochemistry and medicine at Queen's University, neurology training at Western University, and postgraduate training at the Laboratory of Central Nervous System Studies, National Institutes of Health, Bethesda, Maryland. His clinical research focuses on understanding the natural history of ALS (Lou Gehrig’s disease), and in particular the occurrence of “non-motor” manifestations of the disease.

    Michael Strong Photo
  • Western University               

    Dr. Peter Kleinstiver obtained his PhD in Pharmacology and Toxicology from University of Guelph and has over 30 years of experience in healthcare including the design and execution of clinical trials, pharmacoeconomic modeling, health economics, scientific writing, sales and marketing management, and regulatory requirements for medical devices and pharmaceuticals.

    Peter Kleinstiver Photo
  • Sunnybrook Health Sciences Centre

    Dr. Rick Swartz completed his MD and PhD training and neurology residency at the University of Toronto. His appointments and affiliations include Stroke Neurologist, Sunnybrook Health Science Centre; Assistant Professor, Division of Neurology, Department of Medicine, University of Toronto; directing the Sunnybrook Stroke Research Unit; Medical Director, NE-GTA Regional Stroke Network; and Director, University of Toronto Stroke Program.  

    As a clinician-scientist, his clinical specialty is stroke neurology, with a focus on stroke in the young, stroke in pregnancy, intracranial vascular diseases, and the functional consequences of stroke including vascular cognitive impairment. His research focuses on improving functional impairment in stroke – from hyperacute clinical trials to long-term complications, with a focus on intracranial vascular diseases including both small vessel disease and the cognitive impact of stroke and neuroimaging biomarkers of intracranial arterial disease.

    He developed and validated a rapid, feasible screen for three important post-stroke complications (Depression, Obstructive Sleep Apnea and Cognitive impairment (DOC)). He's the principal investigator of a multi-center CIHR-funded study screening thousands of stroke clinic patients for DOC conditions to identify people at high risk of long-term adverse outcomes (recurrent stroke, MI, institutionalization and death). 

    Rick Swartz Photo
  • Western University

    Dr. Rob Hegele is an endocrinologist with an interest in genetics and vascular disease risk. He’s a Scientist, Western University and the Director of the Blackburn Cardiovascular Genetics Lab and London Regional Genomics Centre. He obtained his MD at the University of Toronto with specialty training in internal medicine and endocrinology and followed with postdoctoral training at Rockefeller University and Howard Hughes Medical Institute.

    Rob Hegele Photo
  • Sunnybrook Health Sciences Centre

    Dr. Sandra Black’s current appointments and affiliations include Director of and Senior Scientist in the Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Deborah Ivy Christian Brill Chair in Neurology, Department of Medicine, University of Toronto and Sunnybrook Health Sciences Centre; Site leader, Heart and Stroke Foundation Canadian Partnership for Stroke Recovery; Executive director of Toronto Dementia Research Alliance; and Director, LC Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre; and Affiliate Scientist, Rotman Research Institute, Baycrest and Toronto Rehabilitation Institute.

    She obtained her MD and neurology training at the University of Toronto, postdoctoral training at Western University, and MA equivalent in the history and philosophy of science at Oxford University. Her research has focused on differential diagnosis and treatment of the dementias, cognitive sequelae of stroke and stroke recovery and cerebral small vessel disease. She's led clinical trials in dementia and exploits neuroimaging biomarkers to elucidate brain-behaviour relationships in stroke and dementia, including development of customized brain imaging pipelines to quantify atrophy, focal stroke and white matter disease.

    Photography credit: Curtis Lantinga for Sunnybrook Research Institute.​

    Sandra Black Photo
  • Ontario Brain Institute

    Dr. Sibel Naska is the primary research programs contact for ONDRI at Ontario Brain Institute. She obtained her PhD in neurobiology from Scuola Normale Superiore, Italy and postdoctoral training in neuroscience and stem cell biology at The Hospital for Sick Children. Her research focused on molecular mechanisms involved in remodeling and repairing brain connectivity as well as high throughput drug discovery and drug development. Most recently, Sibel worked at The Hospital for Sick Children as associate research scientist and project manager of a multi site research project focused on regenerative medicine.

     
    Sibel Naska Photo
  • Ontario Brain Institute

    Dr. Tom Mikkelsen is the President & Scientific Director at the Ontario Brain Institute. He received his MD from the University of Calgary and completed clinical training in neurology at the Montreal Neurological Institute. Following this, he did post-doctoral training in tumour and molecular biology at the Ludwig Institute for Cancer Research in Montreal and then in La Jolla, California. Since 1992, he has led the brain tumour program at Henry Ford Hospital and was responsible for building the clinical trials program and laboratory of tumour biology.

    Tom Mikkelsen photo

Steering Committee

  • Baycrest Hospital

    Dr. Angela Troyer is program director of Neuropsychology and Cognitive Health, Professional Practice Chief of Psychology, and Practicum Supervisor, Baycrest Health Sciences; Assistant Professor, University of Toronto; and Adjunct Faculty Member, York University. She obtained her PhD in neuropsychology from the University of Victoria and completed a postdoctoral research fellowship at the Rotman Research Institute of Baycrest Health Sciences. 

    Her primary clinical interest is neuropsychological evaluation of mild cognitive impairment (MCI) and dementia, and memory intervention in normal aging and MCI. Her research interests focus on memory changes in normal aging, MCI, and dementia; effectiveness of memory interventions; and relationship between executive functions and memory.

    Angela Troyer Photo
  • University Health Network

    Dr. Anthony Lang’s current appointments include Director, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital; Director in Division of Neurology, University of Toronto; Lily Safra Chair in Movement Disorders, University Health Network; and Jack Clark Chair, University of Toronto Centre for Research in Neurodegenerative Disease (CRND).

    He trained in internal medicine and neurology at the University of Toronto and completed postgraduate training in movement disorders at Kings College Hospital and the Institute of Psychiatry, England. His research includes clinical studies of poorly recognized neurological disorders, clinical trials of new therapeutic modalities and collaborative basic and clinical studies involving molecular biology, neurophysiology, neuropsychology, and imaging.

    Anthony Lang Photo
  • University Health Network

    Dr. Barry Greenberg is the Director of Strategy for Toronto Dementia Research Alliance and Director, Neuroscience Drug Discovery and Development, University Health Network. He obtained his PhD in genetics from the University of North Carolina. He’s been directly involved in Alzheimer’s disease research and drug discovery since 1985.

    Barry Greenberg Photo
  • University of Waterloo

    Dr. Bill McIlroy is the Chair and Professor, Department of Kinesiology, University of Waterloo. He obtained his PhD in neuroscience from the University of Guelph. His research focuses on understanding how the brain and other parts of the central nervous system control movements of the body and translating this knowledge to help individuals improve their recovery after a neurological injury such as a stroke.

    Bill McIlroy Photo
  • University Health Network

    Dr. Carmela Tartaglia is an Assistant Professor, University of Toronto and maintains a cognitive/behavioral clinic within the University Health Network Memory Clinic. She received her BSc (physiology and minor neuroscience) and MD from McGill University, completed her residency at Western University and did three years of clinical/research fellowship in cognitive/behavioral neurology at the University of California, San Francisco Memory and Aging Center.

    Her clinical and research interests lie in searching for biological markers for diagnosing neurodegenerative diseases including chronic traumatic encephalopathy and frontotemporal lobar degeneration. She uses imaging, pathology and genetics to better understand the pathological substrates that cause cognitive, behavioral and motoric dysfunction in neurodegenerative diseases. The ultimate goal of her research program is to provide early, pathology-specific treatments to her patients.

    Carmela Tartaglia Photo
  • University of Waterloo

    Dr. Chris Hudson is a Professor and Associate Director, Research, School of Optometry, University of Waterloo; Professor, Department of Ophthalmology and Vision Science, University of Toronto; and Senior Scientist,  Toronto Western Research Institute.

    He completed his PhD at the University of Aston, UK and post-doctoral studies at the University of Manchester, UK. Prior to moving to Canada in 2000, he was a Reader in Clinical Vision Science at the School of Biomedical Sciences, University of Ulster, Northern Ireland, UK. His research aims to improve the patho-physiological understanding and clinical monitoring of retinal disease and also to evaluate new techniques in a clinical setting to provide sensitive, objective outcome measures of both retinal and systemic disease.

    Chris Hudson Photo
  • University Health Network

    Dr. Connie Marras is the Associate Professor of Neurology, University of Toronto and a Movement Disorders Neurologist, Toronto Western Hospital Movement Disorders Centre. She completed her MD at Queen’s University, residency and PhD in epidemiology at the University of Toronto, and and further training in epidemiologic research methods at the Parkinson’s Institute in California. Her research focus is the epidemiology of ‘genetic’ forms of movement disorders, prognosis and environmental etiology of movement disorders and evaluating clinical assessment tools (e.g. rating scales for movement disorders).

    Connie Marras Photo
  • St. Michael’s Hospital

    Dr. David Munoz is the Adjunct Scientist, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital; Professor, Laboratory Medicine and Pathobiology, University of Toronto; and Head, Division of Pathology, St. Michael's Hospital. He completed his MD at the University of Navarra. His research interest is focused on neuropathology, particularly the mechanisms of development and progression of degenerative diseases of the brain, including Alzheimer's disease, the non-Alzheimer dementias, movement disorders, and amyotrophic lateral sclerosis.

    Read more.

    David Munoz Photo
  • Western University        

    Dr. Donna Kwan is the Clinical Platform Lead for ONDRI. She completed her MA and PhD in clinical neuropychology at York University, and completed her predoctoral clinical internship at Rush University Medical Center in Chicago. During her PhD studies, she completed practicums at Baycrest Health Sciences, Toronto Rehabilitation Institute, and Sunnybrook Health Sciences Centre.

    DOnna Kwan photo
  • Queen’s University

    Dr. Doug Munoz is the Director, Centre for Neuroscience Studies and Professor in Biomedical and Molecular Sciences, Psychology, and Medicine, Queen’s University. He obtained his PhD in neurology and neurosurgery at McGill University followed by a postdoctoral fellowship at McGill University and subsequently the National Eye Institute, National Institutes of Health.

    The main goals of his research are devoted understanding the neural circuitry controlling visual fixation and the generation of saccadic eye movements and using our knowledge of this circuitry to probe a variety of neurological and psychiatry disorders such as Attention Deficit Hyperactivity Disorder, Parkinson’s disease, Alzheimer’s disease, Tourette’s Syndrome, and amyotrophic lateral sclerosis. He currently holds at Tier 1 Canada Research Chair, is the President of the Canadian Association for Neuroscience and Chair of the Canadian Institute of health Research (CIHR) Institute of Neuroscience, Mental Health and Addiction.

    Doug Munoz Photo
  • St. Joseph’s Health Care

    Dr. Elizabeth Finger is the Associate Professor of Neurology, Western University. She obtained her MD from Cornell University and completed an internship in internal medicine at Massachusetts General Hospital, followed by residency in neurology at Massachusetts General Hospital and Brigham and Women's Hospital in Boston, Massachusetts.

    Her research focuses on understanding the cognitive, neural, and genetic substrates of abnormal decision-making, emotion, and social behavior in frontotemporal dementias and related disorders.

    Elizabeth Finger Photo
  • Western University

    Dr. J.B. Orange’s current affiliations include Professor and Director, School of Communication Sciences and Disorders, Western University; Associate Scientist - Aging, Rehabilitation and Geriatric Care (ARGC), St. Joseph’s Health Care,  Parkwood Hospital and Lawson Health Research Institute; Research Associate, Canadian Centre for Activity and Aging (CCAA); and Member Academic Division of Developmental Disabilities, Department of Psychiatry Schulich School of Medicine & Dentistry. 

    He obtained his PhD at SUNY, Buffalo and completed his postdoctoral studies in Psychiatry at McMaster University. His research focuses on adult neurogenic language and cognitive communication disorders including dementia, aphasia, right hemisphere brain damage, and traumatic brain injury.

    J.B. Orange Photo
  • Sunnybrook Health Sciences Centre

    Dr. Lorne Zinman’s current appointments and affiliations include Associate Professor of Medicine, University of Toronto; Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Staff Neurologist, Director of the ALS Clinic and EMG Laboratory, Sunnybrook Health Sciences Centre; and Chair of the Canadian Amyotrophic Lateral Sclerosis (ALS) Research Network (CALS).

    He received his MD from the University of Calgary and FRCPC in neurology and MSc in clinical epidemiology from the University of Toronto. His main research aim is to better characterize the clinical, electrophysiological and pathological ALS phenotypes along with conducting translational clinical trials.

    Lorne Zinman Photo
  • St. Joseph’s Health Care

    Dr. Manuel Montero-Odasso is the Associate Professor of Medicine, Epidemiology and Biostatistics, Western University and  Internist and Geriatrician, St. Joseph's Health Care London Parkwood Site, London Health Sciences Centre. He completed his MD and PhD at University of Buenos Aires and postdoctoral fellowship at McGill University. His areas of research are the relationship between cognition and mobility in the elderly, gait as an early predictor of frailty and dementia and falls prevention in older people with cognitive impairment.

    Manuel Montero-Odasso Photo
  • Baycrest Hospital

    Dr. Morris Freedman’s current appointments include Head, Division of Neurology, and Scientist, Rotman Research Institute, Baycrest Centre for Geriatric Care; Professor, Faculty of Medicine (Neurology), University of Toronto; and Executive Medical Director Centre for Memory and Neurotherapeutics, Baycrest. His research is aimed at improving the understanding of the mechanisms underlying cognitive impairment due to Alzheimer’s disease and frontotemporal dementia. A major focus is on the study of social cognition in these disorders and on the development of cognitive assessment procedures in dementia.

    Morris Freedman Photo
  • Western University        

    Dr. Paula McLaughlin's current appointments and affiliations include Clinical Neuropsychologist, ONDRI, Western University. She obtained her PhD in clinical psychology at York University, internship in clinical neuropsychology at Emory University – School of Medicine, and postdoctoral fellowship in clinical neuropsychology at the University of California, Los Angeles. Her research focuses on attention, memory, and executive processing, as well as compensatory methods for cognitive decline in healthy aging and individuals with neurodegenerative conditions.

    * Dr. Paula McLaughlin is on maternity leave until April 2017

    Paula McLaughlin Photo
  • Western University               

    Dr. Peter Kleinstiver obtained his PhD in Pharmacology and Toxicology from University of Guelph and has over 30 years of experience in healthcare including the design and execution of clinical trials, pharmacoeconomic modeling, health economics, scientific writing, sales and marketing management, and regulatory requirements for medical devices and pharmaceuticals.

    Peter Kleinstiver Photo
  • Sunnybrook Health Sciences Centre

    Dr. Rick Swartz completed his MD and PhD training and neurology residency at the University of Toronto. His appointments and affiliations include Stroke Neurologist, Sunnybrook Health Science Centre; Assistant Professor, Division of Neurology, Department of Medicine, University of Toronto; directing the Sunnybrook Stroke Research Unit; Medical Director, NE-GTA Regional Stroke Network; and Director, University of Toronto Stroke Program.  

    As a clinician-scientist, his clinical specialty is stroke neurology, with a focus on stroke in the young, stroke in pregnancy, intracranial vascular diseases, and the functional consequences of stroke including vascular cognitive impairment. His research focuses on improving functional impairment in stroke – from hyperacute clinical trials to long-term complications, with a focus on intracranial vascular diseases including both small vessel disease and the cognitive impact of stroke and neuroimaging biomarkers of intracranial arterial disease.

    He developed and validated a rapid, feasible screen for three important post-stroke complications (Depression, Obstructive Sleep Apnea and Cognitive impairment (DOC)). He's the principal investigator of a multi-center CIHR-funded study screening thousands of stroke clinic patients for DOC conditions to identify people at high risk of long-term adverse outcomes (recurrent stroke, MI, institutionalization and death). 

    Rick Swartz Photo
  • Western University

    Dr. Rob Bartha is a Scientist, Robarts Research Institute and Assistant Professor, Department of Diagnostic Radiology and Nuclear Medicine, Western University. He completed his PhD in medical biophysics at Western University. His research is focused on the development of high-field magnetic resonance imaging (MRI) and spectroscopy techniques for early diagnosis of disease and monitoring of treatment response. A major goal is to validate new imaging biomarkers of disease progression and build novel MRI tracers that highlight pathological aspects of a disease process.

  • Western University

    Dr. Rob Hegele is an endocrinologist with an interest in genetics and vascular disease risk. He’s a Scientist, Western University and the Director of the Blackburn Cardiovascular Genetics Lab and London Regional Genomics Centre. He obtained his MD at the University of Toronto with specialty training in internal medicine and endocrinology and followed with postdoctoral training at Rockefeller University and Howard Hughes Medical Institute.

    Rob Hegele Photo
  • Sunnybrook Health Sciences Centre

    Dr. Sandra Black’s current appointments and affiliations include Director of and Senior Scientist in the Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Deborah Ivy Christian Brill Chair in Neurology, Department of Medicine, University of Toronto and Sunnybrook Health Sciences Centre; Site leader, Heart and Stroke Foundation Canadian Partnership for Stroke Recovery; Executive director of Toronto Dementia Research Alliance; and Director, LC Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre; and Affiliate Scientist, Rotman Research Institute, Baycrest and Toronto Rehabilitation Institute.

    She obtained her MD and neurology training at the University of Toronto, postdoctoral training at Western University, and MA equivalent in the history and philosophy of science at Oxford University. Her research has focused on differential diagnosis and treatment of the dementias, cognitive sequelae of stroke and stroke recovery and cerebral small vessel disease. She's led clinical trials in dementia and exploits neuroimaging biomarkers to elucidate brain-behaviour relationships in stroke and dementia, including development of customized brain imaging pipelines to quantify atrophy, focal stroke and white matter disease.

    Photography credit: Curtis Lantinga for Sunnybrook Research Institute.​

     

    Sandra Black Photo
  • Sunnybrook Health Sciences Centre

    Dr. Sean Symons current appointments include Associate Professor of Medical Imaging and Otolaryngology - Head and Neck Surgery, University of Toronto; Deputy Radiologist-in-Chief and Head Division of Neuroradiology, Sunnybrook Health Sciences Centre; and Affiliate Scientist, Sunnybrook Research Institute. He completed his MD at the University of Toronto, residency in diagnostic radiology at Queen’s University, and fellowship in neuroradiology at Harvard University and Massachusetts General Hospital. His research focuses are neurodegenerative, head and neck imaging for cancer and otology, stroke imaging, brain tumour imaging, and neurovascular imaging by computed tomography and magnetic resonance.

    Sean Symons Photo
  • Baycrest Hospital

    Dr. Stephen Strother is a Senior Scientist, Rotman Research Institute, Baycrest and Professor, Department of Medical Biophysics, University of Toronto. He obtained his PhD at the Montreal Neurological Institute, McGill University. His research is directed at developing and testing a set of optimal experimental planning and analysis tools for neuroimaging researchers that are coupled with his own, and others', state-of-the-art neuroimaging research databases.

    Read more.

    Stephen Strother Photo

Publication Committee

  • Western University        

    Dr. Alicia Peltsch obtained her PhD in neuroscience from Queen’s University, and has several years of experience in neuropsychological test administration/scoring and monitoring in research and the clinical trial sector. Her research focused on behavioural inhibition and voluntary movement control in healthy aging and neurodegeneration. Prior to joining ONDRI’s project management team, Alicia was both an ONDRI coordinator in the Memory Disorders Clinic at Hotel Dieu and a research associate with the eye tracking platform.

    Alicia Peltsch photo
  • University Health Network

    Dr. Carmela Tartaglia is an Assistant Professor, University of Toronto and maintains a cognitive/behavioral clinic within the University Health Network Memory Clinic. She received her BSc (physiology and minor neuroscience) and MD from McGill University, completed her residency at Western University and did three years of clinical/research fellowship in cognitive/behavioral neurology at the University of California, San Francisco Memory and Aging Center.

    Her clinical and research interests lie in searching for biological markers for diagnosing neurodegenerative diseases including chronic traumatic encephalopathy and frontotemporal lobar degeneration. She uses imaging, pathology and genetics to better understand the pathological substrates that cause cognitive, behavioral and motoric dysfunction in neurodegenerative diseases. The ultimate goal of her research program is to provide early, pathology-specific treatments to her patients.

    Carmela Tartaglia Photo
  • Ottawa Hospital

    Dr. Dar Dowlatshahi is a Stroke Neurologist, Ottawa Hospital; Assistant Professor and Clinician-Scientist Chair, Department of Medicine, University of Ottawa; Scientific Director, Ottawa Stroke Program; and Scientist, Ottawa Hospital Research Institute.

    He obtained his MD and PhD from McMaster University, then completed a neurology residency at the University of Ottawa and a stroke fellowship at the University of Calgary. He has an active clinical research program in acute stroke and intracerebral hemorrhage, and is funded through the Heart and Stroke Foundation of Canada and CIHR. Through collaborative trials and observational studies, he hopes to discover a treatment for intracerebral hemorrhage.

    Dar Dowlatshahi Photo
  • Western University        

    Dr. Donna Kwan is the Clinical Platform Lead for ONDRI. She completed her MA and PhD in clinical neuropychology at York University, and completed her predoctoral clinical internship at Rush University Medical Center in Chicago. During her PhD studies, she completed practicums at Baycrest Health Sciences, Toronto Rehabilitation Institute, and Sunnybrook Health Sciences Centre.

    Donna Kwan photo
  • Queen’s University

    Dr. Doug Munoz is the Director, Centre for Neuroscience Studies and Professor in Biomedical and Molecular Sciences, Psychology, and Medicine, Queen’s University. He obtained his PhD in neurology and neurosurgery at McGill University followed by a postdoctoral fellowship at McGill University and subsequently the National Eye Institute, National Institutes of Health.

    The main goals of his research are devoted understanding the neural circuitry controlling visual fixation and the generation of saccadic eye movements and using our knowledge of this circuitry to probe a variety of neurological and psychiatry disorders such as Attention Deficit Hyperactivity Disorder, Parkinson’s disease, Alzheimer’s disease, Tourette’s Syndrome, and amyotrophic lateral sclerosis. He currently holds at Tier 1 Canada Research Chair, is the President of the Canadian Association for Neuroscience and Chair of the Canadian Institute of health Research (CIHR) Institute of Neuroscience, Mental Health and Addiction.

    Doug Munoz Photo
  • Thunder Bay Regional Research Institute

  • Sunnybrook Health Sciences Centre

    Dr. Lorne Zinman’s current appointments and affiliations include Associate Professor of Medicine, University of Toronto; Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Staff Neurologist, Director of the ALS Clinic and EMG Laboratory, Sunnybrook Health Sciences Centre; and Chair of the Canadian Amyotrophic Lateral Sclerosis (ALS) Research Network (CALS).

    He received his MD from the University of Calgary and FRCPC in neurology and MSc in clinical epidemiology from the University of Toronto. His main research aim is to better characterize the clinical, electrophysiological and pathological ALS phenotypes along with conducting translational clinical trials.

    Lorne Zinman Photo
  • Sunnybrook Health Sciences Centre

    Dr. Mario Masellis’s current appointments and affiliations include Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Assistant Professor, Neurology, University of Toronto; Research Scientist, Neurogenetics, Centre for Addiction and Mental Health; Clinician-scientist, Neurology, Department of Medicine, Sunnybrook Health Sciences Centre; and Director, Movement Disorders Clinic, Department of Medicine, Sunnybrook. 

    He obtained his MD and PhD in clinical neurosciences from the University of Toronto. His current research focus is on the characterization of the genetics, neuropsychological, neuroimaging, and pathological features of the atypical neurodegenerative dementias. He’s also studying the pharmacogenomics of cholinesterase inhibitors in Parkinson’s disease dementia and dementia with Lewy bodies and anti-parkinsonian medications in Parkinson’s disease. 

    Mario Masellis Photo
  • Western University        

    Dr. Paula McLaughlin's current appointments and affiliations include Clinical Neuropsychologist, ONDRI, Western University. She obtained her PhD in clinical psychology at York University, internship in clinical neuropsychology at Emory University – School of Medicine, and postdoctoral fellowship in clinical neuropsychology at the University of California, Los Angeles. Her research focuses on attention, memory, and executive processing, as well as compensatory methods for cognitive decline in healthy aging and individuals with neurodegenerative conditions.

    * Dr. Paula McLaughlin is on maternity leave until April 2017

    Paula McLaughlin Photo
  • Western University               

    Dr. Peter Kleinstiver obtained his PhD in Pharmacology and Toxicology from University of Guelph and has over 30 years of experience in healthcare including the design and execution of clinical trials, pharmacoeconomic modeling, health economics, scientific writing, sales and marketing management, and regulatory requirements for medical devices and pharmaceuticals.

    Peter Kleinstiver Photo
  • Sunnybrook Health Sciences Centre

    Dr. Sean Symons current appointments include Associate Professor of Medical Imaging and Otolaryngology - Head and Neck Surgery, University of Toronto; Deputy Radiologist-in-Chief and Head Division of Neuroradiology, Sunnybrook Health Sciences Centre; and Affiliate Scientist, Sunnybrook Research Institute. He completed his MD at the University of Toronto, residency in diagnostic radiology at Queen’s University, and fellowship in neuroradiology at Harvard University and Massachusetts General Hospital.

    His research focuses are neurodegenerative, head and neck imaging for cancer and otology, stroke imaging, brain tumour imaging, and neurovascular imaging by computed tomography and magnetic resonance.

    Sean Symons Photo

Recruiting Clinicians

  • Bruyère Continuing Care

    Dr. Andrew Frank is a cognitive and behavioural neurologist focused on early diagnosis and treatment of Alzheimer's disease and other forms of dementia. He's the Medical Director of the Bruyère Memory Program in Ottawa. After obtaining his MD at the University of British Columbia, he completed further training at the Ottawa Hospital and Mayo Clinic in Rochester, Minnesota.

    Read more.

    Andrew Frank Photo
  • University Health Network

    Dr. Anthony Lang’s current appointments include Director, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital; Director in Division of Neurology, University of Toronto; Lily Safra Chair in Movement Disorders, University Health Network; and Jack Clark Chair, University of Toronto Centre for Research in Neurodegenerative Disease (CRND).

    He trained in internal medicine and neurology at the University of Toronto and completed postgraduate training in movement disorders at Kings College Hospital and the Institute of Psychiatry, England. His research includes clinical studies of poorly recognized neurological disorders, clinical trials of new therapeutic modalities and collaborative basic and clinical studies involving molecular biology, neurophysiology, neuropsychology, and imaging.

    Anthony Lang Photo
  • Thunder Bay Regional Research Institute

    Dr. Ayman Hassan's current appointments and affiliations include Neurologist and Medical Lead, Stroke and Neurology Service,Thunder Bay Regional Health Sciences Centre and Assistant Professor, Neurology/Internal Medicine, Clinical Division, Northern Ontario School of Medicine.
     
    He received his MD from Ain Shams University Cairo Egypt. His research focuses on stroke and multiple sclerosis. 
    Ayman Hassan Photo
  • University Health Network

    Dr. Carmela Tartaglia is an Assistant Professor, University of Toronto and maintains a cognitive/behavioral clinic within the University Health Network Memory Clinic. She received her BSc (physiology and minor neuroscience) and MD from McGill University, completed her residency at Western University and did three years of clinical/research fellowship in cognitive/behavioral neurology at the University of California, San Francisco Memory and Aging Center.

    Her clinical and research interests lie in searching for biological markers for diagnosing neurodegenerative diseases including chronic traumatic encephalopathy and frontotemporal lobar degeneration. She uses imaging, pathology and genetics to better understand the pathological substrates that cause cognitive, behavioral and motoric dysfunction in neurodegenerative diseases. The ultimate goal of her research program is to provide early, pathology-specific treatments to her patients.

    Carmela Tartaglia Photo
  • London Health Sciences Centre

    Dr. Christen Shoesmith is the Motor Neuron Diseases Clinic Director and Assistant Professor of Neurology, Western University. She obtained her BSc from the University of Winnipeg and MD from the University of Manitoba and completed her neurology residency at Western University. Her research is focused on clinical trials evaluating treatments to improve prognosis in amyotrophic lateral sclerosis (ALS) and treatments that ameliorate symptoms in ALS and evaluating prognostic factors in ALS and risk factors for developing ALS.

    Christen Shoesmith Photo
  • University Health Network

    Dr. Connie Marras is the Associate Professor of Neurology, University of Toronto and a Movement Disorders Neurologist, Toronto Western Hospital Movement Disorders Centre. She completed her MD at Queen’s University, residency and PhD in epidemiology at the University of Toronto, and and further training in epidemiologic research methods at the Parkinson’s Institute in California. Her research focus is the epidemiology of ‘genetic’ forms of movement disorders, prognosis and environmental etiology of movement disorders and evaluating clinical assessment tools (e.g. rating scales for movement disorders).

    Connie Marras Photo
  • St. Michael’s Hospital

    Dr. Corinne Fischer’s current affiliations include Adjunct Scientist, Keenan Research Centre, Li Ka Shing Knowledge Institute, Neuroscience Division, St. Michael's Hospital; Geriatric Psychiatrist, Department of Psychiatry, St. Michael's Hospital; Director of the Memory Disorders Clinic, Department of Psychiatry, St. Michael's Hospital; Director of the Geriatric Mental Health Outreach Program, Department of Psychiatry, St. Michael's Hospital; and Associate Professor, Division of Geriatric Psychiatry, Department of Psychiatry, University of Toronto.

    She obtained her MD from the University of Toronto and completed her residency in psychiatry and fellowship in geriatric psychiatry at McMaster University. She also completed her geriatric psychiatry subspecialty certification. Her research focus includes cognitive reserve and neuropsychiatric symptoms in dementia.

    Corinne Fischer Photo
  • Providence Care Mental Health Services and Queen's University

    Dr. Dallas Seitz is a psychiatrist and Assistant Professor and Clinician Scientist at Queen's University. He obtained his MD from the University of Saskatchewan and completed his psychiatric residency training at Queen’s University, fellowship training at the University of Toronto, and PhD in clinical epidemiology and health services research at the University of Toronto.

    His current research examines health service utilization of older adults with psychiatric disorders; evaluation of the safety and efficacy of treatments for geriatric mental health conditions; and, knowledge translation in geriatric mental health.

    Dallas Seitz photo
  • Ottawa Hospital

    Dr. Dar Dowlatshahi is a Stroke Neurologist, Ottawa Hospital; Assistant Professor and Clinician-Scientist Chair, Department of Medicine, University of Ottawa; Scientific Director, Ottawa Stroke Program; and Scientist, Ottawa Hospital Research Institute.

    He obtained his MD and PhD from McMaster University, then completed a neurology residency at the University of Ottawa and a stroke fellowship at the University of Calgary. He has an active clinical research program in acute stroke and intracerebral hemorrhage, and is funded through the Heart and Stroke Foundation of Canada and CIHR. Through collaborative trials and observational studies, he hopes to discover a treatment for intracerebral hemorrhage.

    Dar Dowlatshahi Photo
  • Ottawa Hospital

    Dr. David Grimes is the Associate Scientist, Neuroscience Program, Ottawa Hospital Research Institute; Chair and Chief, Neurology/Medicine, University of Ottawa; Associate Professor, Neurology/Medicine, University of Ottawa; Director, Parkinson's Disease and Movement Disorders Clinic, Ottawa Hospital; and Co-Director, Parkinson Research Consortium, University of Ottawa.

    He obtained his MD and completed his residency in neurology at the University of Ottawa. His major clinical interests are in the diagnosis and treatment of a wide variety of movement disorders with an emphasis on Parkinson's disease and dystonia. His research focus is in movement disorders with a focus on Parkinson's disease.

    David Grimes Photo
  • University Health Network

    Dr. David Tang-Wai is an Associate Professor, Neurology and Geriatric Medicine, University of Toronto; Co-director, University Health Network Memory Clinic, University of Toronto; and Behavioural Neurologist, Centre for Addiction and Mental Health (CAMH) Memory Clinic, and Program Director, Adult Neurology Residency Program, University of Toronto.

    He obtained his MD from McGill University and completed his neurology residency and behavioural neurology fellowship at the Mayo Clinic. His research interests include the atypical presentations of Alzheimer’s disease, including posterior cortical atrophy, driving and dementia, the progressive aphasias, and the potential treatment of Alzheimer’s disease with deep brain stimulation.

    David Tang-Wai Photo
  • Hamilton Health Sciences Centre

    Dr. Demetrios Sahlas is MG DeGroote Professor in Stroke Management, Department of Medicine, Faculty of Health Sciences, McMaster University; Associate Professor, Division of Neurology, Department of Medicine, McMaster University; and Central South Regional Stroke Centre, Hamilton General Hospital, Hamilton Health Sciences.

    He obtained his MD from McMaster University and completed his postgraduate training in neurology at McGill University, followed by a clinical research fellowship in behavioural neurology and stroke at the University of Toronto. His research interests include the diagnosis and management of carotid artery disease, the use of transcranial doppler (TCD) ultrasound in the prevention and treatment of cerebrovascular disease, and the cognitive and neuropathological correlates of chronic microvascular ischemic changes involving the periventricular and subcortical white matter.

    Read more.

    Demetrios Sahlas Photo
  • St. Joseph’s Health Care

    Dr. Elizabeth Finger is the Associate Professor of Neurology, Western University. She obtained her MD from Cornell University and completed an internship in internal medicine at Massachusetts General Hospital, followed by residency in neurology at Massachusetts General Hospital and Brigham and Women's Hospital in Boston, Massachusetts.

    Her research focuses on understanding the cognitive, neural, and genetic substrates of abnormal decision-making, emotion, and social behavior in frontotemporal dementias and related disorders.

    Elizabeth Finger Photo
  • St. Michael’s Hospital

    Dr. Gustavo Saposnik’s current affiliations include Associate Professor of Medicine (Neurology), University of Toronto; Staff Neurologist, St. Michael's Hospital; Director of the Stroke Outcomes Research Center, Li Ka Shing Knowledge Institute; and he holds cross appointments at the Institute of Clinical Evaluative Sciences (ICES) and at Institute of Health Policy, Management and Evaluation. He obtained his MD at University of Buenos Aires and MSc in clinical effectiveness at Harvard School of Public Health and University of Buenos Aires. His research focus is stroke outcomes research, including three levels of intervention: Acute stroke care, stroke prevention and stroke rehabilitation.

    Gustavo Saposnik Photo
  • London Health Sciences Centre

    Dr. Jennifer Mandzia is an Assistant Professor of Neurology, Western University and Co-Medical Director, Southwestern Ontario Stroke Network.

    She obtained her PhD in neuroscience from the University of Toronto. Her doctoral thesis was on functional MRI (fMRI) in patients with mild cognitive impairment (MCI) and structural neuroimaging correlates. She obtained her MD from the University of Ottawa and completed her neurology training at Western University. She then completed a one year stroke fellowship at the University of Calgary, Calgary Stroke Program. Her research interests include cognition in stroke, minor stroke and Transient Ischemic Attack (TIA), stroke in the young, and acute stroke.

    Jennifer Mandzia Photo
  • Hamilton Health Sciences Centre

    Dr. John Turnbull's current appointments and affiliations include Professor and Head, Division of Neurology, Department of Medicine, McMaster University and Andrew Bruce Douglas Chair in Neurology, McMaster University.

    He received his BSc from York University, MSc from Université Laval, PhD in pharmacology and toxicology from the University of Montreal, and MD from Western University. He obtained his fellowship in internal medicine from McMaster University and his fellowship in neurology from Western University. He undertook two years of postdoctoral training at the University of California (Irvine) at the Centre for the Neurobiology of Learning and Memory.

    His primary clinical interests are in motor neuron diseases. He has an active laboratory investigating models of amyotrophic lateral sclerosis (ALS) using transgenic animals and molecular biological approaches, and is involved actively in clinical trials in ALS.

    John Turnbull Photo
  • University Health Network

    Dr. Leanne Casaubon is an Assistant Professor, Department of Medicine, University of Toronto; Clinician Investigator and Neurologist, Division of Neurology and the Stroke Program, Toronto Western Hospital (TWH)/University Health Network; and Director of the TIA and Minor Stroke (TAMS) Unit, TWH. She obtained her MD at Dalhousie University and completed neurology residency training, followed by a stroke fellowship and MSc in clinical epidemiology at the University of Toronto.

    Her clinical and academic interests include developing and evaluating patient care models for improving stroke care and secondary stroke prevention. She’s developed expertise in best practices and quality improvement and is currently leading the 2014-2015 update of the Canadian Stroke Best Practice Recommendations - Hyperacute Care and Acute Care sections as co-chair. She’s also involved in the Ontario Stroke System and as an invited member of the Ontario Vascular Health Primary Care Work Group as a stroke expert to lead in the integration of health groups and initiatives for optimal vascular health for people in Ontario.

    Leanne Casaubon Photo
  • Sunnybrook Health Sciences Centre

    Dr. Lorne Zinman’s current appointments and affiliations include Associate Professor of Medicine, University of Toronto; Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Staff Neurologist, Director of the ALS Clinic and EMG Laboratory, Sunnybrook Health Sciences Centre; and Chair of the Canadian Amyotrophic Lateral Sclerosis (ALS) Research Network (CALS).

    He received his MD from the University of Calgary and FRCPC in neurology and MSc in clinical epidemiology from the University of Toronto. His main research aim is to better characterize the clinical, electrophysiological and pathological ALS phenotypes along with conducting translational clinical trials.

    Lorne Zinman Photo
  • London Health Sciences Centre

    Dr. Mandar Jog is the Director of the National Parkinson Foundation Centre of Excellence, London Health Sciences Centre; Director of the Movement Disorders Program, London, Ontario; and Professor of Neurology, Western University.

    He trained in neurology in Toronto and completed a fellowship in movement disorders followed by a postdoctoral fellowship in computational neuroscience at the Massachusetts Institute of Technology (MIT), Boston and a Visiting Professorship at Stanford Research Institute, California. His research interests include motor control, neurophysiology and computational modeling, multichannel recording and web-based teaching of movement disorders. His research attempts to answer the structure and function of the basal ganglia and their role in movement disorders.

    Mandar Jog Photo
  • Sunnybrook Health Sciences Centre

    Dr. Mario Masellis’s current appointments and affiliations include Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Assistant Professor, Neurology, University of Toronto; Research Scientist, Neurogenetics, Centre for Addiction and Mental Health; Clinician-scientist, Neurology, Department of Medicine, Sunnybrook Health Sciences Centre; and Director, Movement Disorders Clinic, Department of Medicine, Sunnybrook. 

    He obtained his MD and PhD in clinical neurosciences from the University of Toronto. His current research focus is on the characterization of the genetics, neuropsychological, neuroimaging, and pathological features of the atypical neurodegenerative dementias. He’s also studying the pharmacogenomics of cholinesterase inhibitors in Parkinson’s disease dementia and dementia with Lewy bodies and anti-parkinsonian medications in Parkinson’s disease. 

    Mario Masellis Photo
  • St. Joseph’s Health Care

    Dr. Michael Borrie’s current positions and appointments include Professor, Department of Medicine, Division of Geriatric Medicine, Western University; Head, Department of Geriatric Medicine, Parkwood Hospital; Medical Director, Aging Brain and Memory Clinic, Parkwood Hospital; Medical Director, Dementia Special Care Unit, Western Counties Wing, Parkwood Hospital; Program Director, Southwestern Ontario Regional Geriatric Program; Chair, Protocol Review and Selection Committee, Consortium of Canadian Centres for Clinical Cognitive Research (C5R); and Director, Geriatric Clinical Trials Group, Lawson Research Institute, Parkwood Hospital.

    He obtained his MD from the University of Otago, New Zealand. His research interests include predictors of conversion from mild cognitive impairment to Alzheimer’s disease, including sensitive neuroimaging techniques, and the clinical evaluation of new treatments for Alzheimer’s disease, geriatric rehabilitation and falls in the elderly.

    Michael Borrie Photo
  • Baycrest Hospital

    Dr. Morris Freedman’s current appointments include Head, Division of Neurology, and Scientist, Rotman Research Institute, Baycrest Centre for Geriatric Care; Professor, Faculty of Medicine (Neurology), University of Toronto; and Executive Medical Director Centre for Memory and Neurotherapeutics, Baycrest. His research is aimed at improving the understanding of the mechanisms underlying cognitive impairment due to Alzheimer’s disease and frontotemporal dementia. A major focus is on the study of social cognition in these disorders and on the development of cognitive assessment procedures in dementia.

    Morris Freedman Photo
  • Sunnybrook Health Sciences Centre

    Dr. Rick Swartz completed his MD and PhD training and neurology residency at the University of Toronto. His appointments and affiliations include Stroke Neurologist, Sunnybrook Health Science Centre; Assistant Professor, Division of Neurology, Department of Medicine, University of Toronto; directing the Sunnybrook Stroke Research Unit; Medical Director, NE-GTA Regional Stroke Network; and Director, University of Toronto Stroke Program.  

    As a clinician-scientist, his clinical specialty is stroke neurology, with a focus on stroke in the young, stroke in pregnancy, intracranial vascular diseases, and the functional consequences of stroke including vascular cognitive impairment. His research focuses on improving functional impairment in stroke – from hyperacute clinical trials to long-term complications, with a focus on intracranial vascular diseases including both small vessel disease and the cognitive impact of stroke and neuroimaging biomarkers of intracranial arterial disease.

    He developed and validated a rapid, feasible screen for three important post-stroke complications (Depression, Obstructive Sleep Apnea and Cognitive impairment (DOC)). He's the principal investigator of a multi-center CIHR-funded study screening thousands of stroke clinic patients for DOC conditions to identify people at high risk of long-term adverse outcomes (recurrent stroke, MI, institutionalization and death). 

    Rick Swartz Photo
  • Sunnybrook Health Sciences Centre

    Dr. Sandra Black’s current appointments and affiliations include Director of and Senior Scientist in the Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Deborah Ivy Christian Brill Chair in Neurology, Department of Medicine, University of Toronto and Sunnybrook Health Sciences Centre; Site leader, Heart and Stroke Foundation Canadian Partnership for Stroke Recovery; Executive director of Toronto Dementia Research Alliance; and Director, LC Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre; and Affiliate Scientist, Rotman Research Institute, Baycrest and Toronto Rehabilitation Institute.

    She obtained her MD and neurology training at the University of Toronto, postdoctoral training at Western University, and MA equivalent in the history and philosophy of science at Oxford University. Her research has focused on differential diagnosis and treatment of the dementias, cognitive sequelae of stroke and stroke recovery and cerebral small vessel disease. She's led clinical trials in dementia and exploits neuroimaging biomarkers to elucidate brain-behaviour relationships in stroke and dementia, including development of customized brain imaging pipelines to quantify atrophy, focal stroke and white matter disease.

    Photography credit: Curtis Lantinga for Sunnybrook Research Institute.​

    Sandra Black Photo
  • Centre for Addiction and Mental Health

    Dr. Sanjeev Kumar is a Clinicial Research Fellow, Centre for Addiction and Mental Health (CAMH), University of Toronto. He completed his psychiatry residency at the Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, Virginia. He completed his Geriatric Psychiatry Fellowship at  Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh. Previously he obtained his Bachelor of Medicine and Bachelor of Surgery at Government Medical College, Patiala, India and served in the Indian Army as a physician.

    Read more.

    Sanjeev Kumar Photo
  • St. Joseph’s Health Care

    Dr. Stephen Pasternak is an Associate Professor, Department of Clinical Neurological Sciences, Western University and a Scientist, Robarts Research Institute. He obtained his MD and PhD in the Department of Neurology and Neurosurgery at McGill University and completed his neurology residency at the University of Toronto, postdoctoral training in cell biology at the Hospital of Sick Children in Toronto and fellowship training in cognitive neurology at the University of Toronto.

    His laboratory at the Robarts Research Institute is focused on understanding the production of beta-amyloid, focusing on cell biology of the endosomal/lysosomal system, and on developing contrast agents to diagnose Alzheimer’s disease using non-invasive imaging. At his clinic in Cognitive Neurology and Alzheimer's Disease Research Centre at the Parkwood Institute, he sees patients with neurodegenerative disease with an interest in Alzheimer’s disease, Parkinson’s Disease Dementia and Lewy Body Dementia. 

    Stephen Pasternak Photo
  • St. Michael’s Hospital

    Dr. Tom Steeves is the Staff Physician, Adult Neurology at St. Michael's Hospital, Assistant Professor of Medicine at the University of Toronto and runs the Movement Disorders Clinic at St. Michael’s Hospital. He obtained his MD at the University of Saskatchewan and completed his internship and residency in neurology at the Mayo Clinic in Rochester, Minnesota. His academic interests have related primarily to translational research and epidemiology projects relating to Dystonia, Tourette Syndrome and Parkinson’s disease.

    Tom Steeves Photo

Assessment Platforms

  • St. Joseph’s Health Care

    Dr. Angela Roberts is a postdoctoral fellow with the Aging, Rehabilitation and Geriatric Care Research Center, cognitive neurology, Parkwood Institute; limited duties faculty, School of Communication Sciences and Disorders, Western University; and a member of the Research Policy Committee, Parkinson Society Canada. She completed her PhD in the Faculty of Health and Rehabilitation Sciences at Western University and her MA and BA in Speech-Language Pathology at The University of Tennessee.

    Her expertise is in cognition and language in neurodegenerative disorders. Her work focuses on Parkinson’s disease, amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Her interests include semantics and the coupling between motor cognition and language. One of her unique research areas is the use of spontaneous spoken language to discriminate among dementia profiles. These profiles may detect early and subtle changes in cognition, language, and motor speech that may not be discernible using traditional standardized measures of cognition and language. Her work also seeks to understand the neurological substrates of spoken language in the context of normal aging and in neurodegeneration.

    Read more.

    Angela Roberts Photo
  • Baycrest Hospital

    Dr. Angela Troyer is program director of Neuropsychology and Cognitive Health, Professional Practice Chief of Psychology, and Practicum Supervisor, Baycrest Health Sciences; Assistant Professor, University of Toronto; and Adjunct Faculty Member, York University. She obtained her PhD in neuropsychology from the University of Victoria and completed a postdoctoral research fellowship at the Rotman Research Institute of Baycrest Health Sciences. 

    Her primary clinical interest is neuropsychological evaluation of mild cognitive impairment (MCI) and dementia, and memory intervention in normal aging and MCI. Her research interests focus on memory changes in normal aging, MCI, and dementia; effectiveness of memory interventions; and relationship between executive functions and memory.

    Angela Troyer Photo
  • Ontario Cancer Biomarker Network

    Dr. Anthony Vaccarino is Director of Clinical Research at Indoc Research where he oversees research programs, including the design, analysis and execution of clinical trials. Prior to joining the team, he was with the International Society for Central Nervous System (CNS) Drug Development; a non-profit independent society focused on addressing scientific challenges in drug development. He has held positions as full professor at the University of New Orleans and the Louisiana State University Neuroscience Center, where he oversaw federally-funded research programs examining the psychological and physiological organization of pain processes and addiction, and served as Chair of the Institutional Research Ethics Board.

    He’s also served as Chief Scientific Officer and Director of Preclinical Development for pharmaceutical start-ups, where he oversaw the development of novel patented CNS compounds that have resulted in clinical candidates for pain, depression and anxiety. He received his PhD from McGill University and was an NSERC postdoctoral fellow in neurosciences at University of California, Los Angeles.

    Anthony Vaccarino Photo
  • University Health Network

    Dr. Barry Greenberg is the Director of Strategy for Toronto Dementia Research Alliance and Director, Neuroscience Drug Discovery and Development, University Health Network. He obtained his PhD in genetics from the University of North Carolina. He’s been directly involved in Alzheimer’s disease research and drug discovery since 1985.

    Barry Greenberg Photo
  • University of Waterloo

    Dr. Bill McIlroy is the Chair and Professor, Department of Kinesiology, University of Waterloo. He obtained his PhD in neuroscience from the University of Guelph. His research focuses on understanding how the brain and other parts of the central nervous system control movements of the body and translating this knowledge to help individuals improve their recovery after a neurological injury such as a stroke.

    Bill McIlroy Photo
  • Baycrest Health Sciences

    Dr. Brian Levine is a Senior Scientist, Rotman Research Institute at Baycrest Health Sciences; Professor, Psychology and Medicine (Neurology), University of Toronto; Baycrest Site Leader, Canadian Partnership for Stroke Recovery; and clinical neuropsychologist.

    He's interested in the function and dysfunction of large-scale neural systems as expressed in complex human behaviours, including episodic and autobiographical memory and executive functioning. His research is focused on developing empirically supported measures of naturalistic mnemonic and executive processes and using these to inform both theory and clinical practice. Dr. Levine uses novel assessment techniques, coupled with multimodal neuroimaging in his research.

    Brian Levine Photo
  • University of Waterloo

    Dr. Chris Hudson is a Professor and Associate Director, Research, School of Optometry, University of Waterloo; Professor, Department of Ophthalmology and Vision Science, University of Toronto; and Senior Scientist,  Toronto Western Research Institute.

    He completed his PhD at the University of Aston, UK and post-doctoral studies at the University of Manchester, UK. Prior to moving to Canada in 2000, he was a Reader in Clinical Vision Science at the School of Biomedical Sciences, University of Ulster, Northern Ireland, UK. His research aims to improve the patho-physiological understanding and clinical monitoring of retinal disease and also to evaluate new techniques in a clinical setting to provide sensitive, objective outcome measures of both retinal and systemic disease.

    Chris Hudson Photo
  • St. Michael’s Hospital

    Dr. David Munoz is the Adjunct Scientist, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital; Professor, Laboratory Medicine and Pathobiology, University of Toronto; and Head, Division of Pathology, St. Michael's Hospital. He completed his MD at the University of Navarra. His research interest is focused on neuropathology, particularly the mechanisms of development and progression of degenerative diseases of the brain, including Alzheimer's disease, the non-Alzheimer dementias, movement disorders, and amyotrophic lateral sclerosis.

    Read more.

    David Munoz Photo
  • University of Ottawa

    Dr. David Park is a Professor and Director of the University of Ottawa Brain and Mind Research Institute. He obtained his PhD in biochemistry at Rutgers University, New Jersey. His research focuses on deciphering the mechanisms governing neurodegeneration/injury and development with a substantial effort focused on Parkinson’s disease and stroke.

    David Park Photo
  • Children's Hospital of Eastern Ontario (CHEO)

    Dr. Dennis Bulman is a Senior Scientist, CHEO Research Institute & Newborn Screening Ontario; Affiliate Member, Regenerative Medicine Program at OHRI; and Professor, Department of Pediatrics, Faculty of Medicine, University of Ottawa. He obtained his MSc in microbiology and immunology at Western University, PhD in molecular and medical genetics at the University of Toronto.

    His research interests involve the identification of genes for rare genetic disorders, the translation of these discoveries to the clinic and the implementation of new molecular testing paradigms into newborn screening. His lab uses a variety of genetic technologies from genetic mapping, candidate Sanger sequencing, comparative genomic hydridization (CGH), and exome and whole genome sequencing.

    Dennis Bullman Photo
  • Western University        

    Dr. Donna Kwan is the Clinical Platform Lead for ONDRI. She completed her MA and PhD in clinical neuropychology at York University, and completed her predoctoral clinical internship at Rush University Medical Center in Chicago. During her PhD studies, she completed practicums at Baycrest Health Sciences, Toronto Rehabilitation Institute, and Sunnybrook Health Sciences Centre.

    Donna Kwan photo
  • Queen’s University

    Dr. Doug Munoz is the Director, Centre for Neuroscience Studies and Professor in Biomedical and Molecular Sciences, Psychology, and Medicine, Queen’s University. He obtained his PhD in neurology and neurosurgery at McGill University followed by a postdoctoral fellowship at McGill University and subsequently the National Eye Institute, National Institutes of Health.

    The main goals of his research are devoted understanding the neural circuitry controlling visual fixation and the generation of saccadic eye movements and using our knowledge of this circuitry to probe a variety of neurological and psychiatry disorders such as Attention Deficit Hyperactivity Disorder, Parkinson’s disease, Alzheimer’s disease, Tourette’s Syndrome, and amyotrophic lateral sclerosis. He currently holds at Tier 1 Canada Research Chair, is the President of the Canadian Association for Neuroscience and Chair of the Canadian Institute of health Research (CIHR) Institute of Neuroscience, Mental Health and Addiction.

    Doug Munoz Photo
  • University of Toronto

    Dr. Ekaterina Rogaeva is an Associate Professor, Department of Medicine, University of Toronto and has a Chair position in Research on Dementia with Lewy Bodies, Tanz Centre for Research in Neurodegenerative Diseases (CRND). She obtained her PhD in biochemistry at Moscow State University, Russia. Since 1992, she’s been conducting molecular genetics research on neurodegenerative diseases at the University of Toronto and the Tanz Centre for Research in Neurodegenerative Diseases. She's contributed substantially to the development of effective genetic testing of different forms of dementia in clinical practice and played a central role in the discovery and characterization of the two presenilin genes responsible for the most aggressive early-onset form of Alzheimer’s disease.

    Ekaterina Rogaeva Photo
  • Western University

    Dr. Guangyong (G. Y.) Zou is a Professor and Undergraduate Chair, Department of Epidemiology and Biostatistics, and Scientist, Robarts Research Institute, Western University. He obtained his PhD in plant science at the University of Connecticut and PhD in biostatistics at Western University. He focuses on developing and evaluating statistical methods that are useful for medical research, with an emphasis on effect estimation in clinical trials and epidemiologic studies.

    G. Y. Zou Photo
  • Western University

    Dr. J.B. Orange’s current affiliations include Professor and Director, School of Communication Sciences and Disorders, Western University; Associate Scientist - Aging, Rehabilitation and Geriatric Care (ARGC), St. Joseph’s Health Care,  Parkwood Hospital and Lawson Health Research Institute; Research Associate, Canadian Centre for Activity and Aging (CCAA); and Member Academic Division of Developmental Disabilities, Department of Psychiatry Schulich School of Medicine & Dentistry. 

    He obtained his PhD at SUNY, Buffalo and completed his postdoctoral studies in Psychiatry at McMaster University. His research focuses on adult neurogenic language and cognitive communication disorders including dementia, aphasia, right hemisphere brain damage, and traumatic brain injury.

    J.B. Orange Photo
  • Western University

  • St. Joseph’s Health Care

    Dr. Manuel Montero-Odasso is the Associate Professor of Medicine, Epidemiology and Biostatistics, Western University and  Internist and Geriatrician, St. Joseph's Health Care London Parkwood Site, London Health Sciences Centre. He completed his MD and PhD at University of Buenos Aires and postdoctoral fellowship at McGill University. His areas of research are the relationship between cognition and mobility in the elderly, gait as an early predictor of frailty and dementia and falls prevention in older people with cognitive impairment.

    Manuel Montero-Odasso Photo
  • Ontario Cancer Biomarker Network

    Moyez Dharsee is CIO and Director of Informatics at Indoc Research where he leads bioinformatics and software development operations. In collaboration with a consortium of informatics groups from Baycrest, Queen's University, and the Children's Hospital of Eastern Ontario, he manages the development of high-performance tools and platforms to support regional and international research programs, including the Ontario Brain Institute's Brain-CODE platform. He also oversees the development of algorithms for genomics data processing, data mining, and pathway analysis. He obtained his BSc in computer science from the University of Toronto.

    Moyez Dharsee Photo
  • Western University        

    Dr. Paula McLaughlin's current appointments and affiliations include Clinical Neuropsychologist, ONDRI, Western University. She obtained her PhD in clinical psychology at York University, internship in clinical neuropsychology at Emory University – School of Medicine, and postdoctoral fellowship in clinical neuropsychology at the University of California, Los Angeles. Her research focuses on attention, memory, and executive processing, as well as compensatory methods for cognitive decline in healthy aging and individuals with neurodegenerative conditions.

    * Dr. Paula McLaughlin is on maternity leave until April 2017

    Paula McLaughlin Photo
  • Western University

    Dr. Rob Bartha is a Scientist, Robarts Research Institute and Assistant Professor, Department of Diagnostic Radiology and Nuclear Medicine, Western University. He completed his PhD in medical biophysics at Western University. His research is focused on the development of high-field magnetic resonance imaging (MRI) and spectroscopy techniques for early diagnosis of disease and monitoring of treatment response. A major goal is to validate new imaging biomarkers of disease progression and build novel MRI tracers that highlight pathological aspects of a disease process.

    Rob Bartha Photo
  • Western University

    Dr. Rob Hegele is an endocrinologist with an interest in genetics and vascular disease risk. He’s a Scientist, Western University and the Director of the Blackburn Cardiovascular Genetics Lab and London Regional Genomics Centre. He obtained his MD at the University of Toronto with specialty training in internal medicine and endocrinology and followed with postdoctoral training at Rockefeller University and Howard Hughes Medical Institute.

    Rob Hegele Photo
  • Sunnybrook Health Sciences Centre

    Dr. Sean Symons current appointments include Associate Professor of Medical Imaging and Otolaryngology - Head and Neck Surgery, University of Toronto; Deputy Radiologist-in-Chief and Head Division of Neuroradiology, Sunnybrook Health Sciences Centre; and Affiliate Scientist, Sunnybrook Research Institute. He completed his MD at the University of Toronto, residency in diagnostic radiology at Queen’s University, and fellowship in neuroradiology at Harvard University and Massachusetts General Hospital. His research focuses are neurodegenerative, head and neck imaging for cancer and otology, stroke imaging, brain tumour imaging, and neurovascular imaging by computed tomography and magnetic resonance.

    Sean Symons Photo
  • Baycrest Hospital

    Dr. Stephen Strother is a Senior Scientist, Rotman Research Institute, Baycrest and Professor, Department of Medical Biophysics, University of Toronto. He obtained his PhD at the Montreal Neurological Institute, McGill University. His research is directed at developing and testing a set of optimal experimental planning and analysis tools for neuroimaging researchers that are coupled with his own, and others', state-of-the-art neuroimaging research databases.

    Read more.

    Stephen Strother Photo
  • St. Michael’s Hospital

    Dr. Tom Schweizer’s current affiliations include Director, Neuroscience Research Program, St. Michael’s Hospital; Scientist, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital; Assistant Professor, Faculty of Neuroscience (Neurosurgery), University of Toronto; and Assistant Professor, Institute of Biomaterials and Biomedical Engineering, University of Toronto.

    He obtained his PhD in behavioural neuroscience at the University of Waterloo and fellowship in cognitive neuroscience at Rotman Research Institute. His research is focused on the neural bases of human cognitive and real-world functioning using experimental cognitive paradigms, neuroimaging and neuropsychology.

    Tom Schweizer Photo
  • University of Toronto

    Dr. Wendy Lou is a Professor of Biostatistics and Statistics and Head of the Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto. She’s a Fellow of the American Statistical Association (ASA) and holds the Canada Research Chair in Statistical Methods for Health Care. She's been the principal investigator or a co-investigator on numerous statistical methodology grants and interdisciplinary research projects, funded by government agencies in Canada and the United States. Her research work focuses on the development of statistical methodology for the study of chronic conditions and quality improvement, as well as on biomedical applications of the distribution theory of runs and patterns.

    Wendy Lou Photo
  • Queen’s University

    Dr. Ying Chen is an ONDRI Scholar and a postdoctoral fellow at Queen’s University working with Dr. Doug Munoz. Her research focus is studying neurodegenerative diseases using saccadic tasks along with other assessments to identify the eye-tracking behavioral biomarkers. She was a neurologist in China where she obtained her clinical experience.

    Ying Chen photo

Project Management

  • Western University        

    Dr. Alicia Peltsch obtained her PhD in neuroscience from Queen’s University, and has several years of experience in neuropsychological test administration/scoring and monitoring in research and the clinical trial sector. Her research focused on behavioural inhibition and voluntary movement control in healthy aging and neurodegeneration. Prior to joining ONDRI’s project management team, Alicia was both an ONDRI coordinator in the Memory Disorders Clinic at Hotel Dieu and a research associate with the eye tracking platform.

    Alicia Peltsch photo
  • Western University

    Andrea develops all ONDRI communications, including the website, videos, newsletters, speaking remarks, and presentations. Andrea studied business and psychology at the University of Waterloo and has more than 13 years of experience working in communications, marketing and human resources in various industries including education, technology, defence, and finance.

    Andrea Richter Photo
  • Western University

    Catarina obtained her BSc in biomedical sciences in Portugal, MSc in global health in the Netherlands, and post graduate studies in lab management, health engineering and social rehabilitation. She worked as a biomedical scientist in labs for 12 years and later spent six years teaching lab technology, clinical chemistry and lab management in BSc biomedical sciences. Prior to ONDRI, she implemented the first Nurses and Midwife school in East Timor, Asia. Recently, she was the ONDRI ALS Research Coordinator at Sunnybrook Health Sciences Centre.
    Catarina Downey Photo
  • Western University        

    Dr. Donna Kwan is the Clinical Platform Lead for ONDRI. She completed her MA and PhD in clinical neuropychology at York University, and completed her predoctoral clinical internship at Rush University Medical Center in Chicago. During her PhD studies, she completed practicums at Baycrest Health Sciences, Toronto Rehabilitation Institute, and Sunnybrook Health Sciences Centre.

    Donna Kwan photo
  • Donna has over 40 years of experience as a registered nurse having worked in obstetrics, emergency and clinical trials. She was involved in the ONDRI start up and her primary responsibilities include monitoring, protocol adherence, and assisting with Lawson Health Research Institute contracts for the principal investigators.

    Donna McBain Photo
  • Heather has been involved in all aspects of clinical trials since 1996, with experience primarily in neurology (stroke) and cardiology research.  Prior to joining ONDRI, Heather owned "Clinitrials" a successful research coordinating business. She spent many years working in emergency and the intensive care unit, holds a Certificate in Hospital Administration and is a registered nurse and Certified Clinical Research Coordinator with the Association of Clinical Research Professionals.

    Heather Hink Photo
  • Lindsey is involved with protocol development and amendments, ethics submissions, case report form creation and revisions, as well as performing the eye-tracking assessments for all the London sites. She works closely with Brain-CODE providing input for development and data uploads. She studied biomedical science at the University of Guelph and she has more than 10 years of experience working in clinical trials, both pharmaceutical and investigator initiated studies in various diseases.

    Lindsey McLeish Photo
  • Western University

    Lisa is the first point of contact for the ONDRI project management team and provides financial and administrative support to the entire ONDRI team. She graduated from Western University with a degree in psychology and continued to work at Western as a Program Assistant/Manager in a number of faculties including Social Science and Engineering, as well as working as a Technology Transfer Coordinator in Research Services. Most recently, Lisa was a Project Assistant with St. Joseph's Health Care working on the Vision Care Project for the South West Local Health Integrated Network.

    Lisa Desalaiz Photo
  • Western University        

    Dr. Paula McLaughlin's current appointments and affiliations include Clinical Neuropsychologist, ONDRI, Western University. She obtained her PhD in clinical psychology at York University, internship in clinical neuropsychology at Emory University – School of Medicine, and postdoctoral fellowship in clinical neuropsychology at the University of California, Los Angeles. Her research focuses on attention, memory, and executive processing, as well as compensatory methods for cognitive decline in healthy aging and individuals with neurodegenerative conditions.

    * Dr. Paula McLaughlin is on maternity leave until April 2017

    Paula McLaughlin Photo
  • Western University               

    Dr. Peter Kleinstiver obtained his PhD in Pharmacology and Toxicology from University of Guelph and has over 30 years of experience in healthcare including the design and execution of clinical trials, pharmacoeconomic modeling, health economics, scientific writing, sales and marketing management, and regulatory requirements for medical devices and pharmaceuticals.

    Peter Kleinstiver Photo
  • Western University

    Sean coordinates financial management and timely and accurate financial reporting at each of the hospital sites enrolling participants within Ontario. He has over 25 years of experience working as an accountant including eight years as a Controller.

    Sean Lucas Photo

Founding Authors

  • Founding authors definition

    Individuals who made a significant initial, as well as ongoing, contribution to the original protocol design through writing, review and workshop attendance; acting as Disease Theme or Platform Leads/Co-leads; and/or members of the Executive Committee.

    These individuals will be collectively listed on all ONDRI publications as the “ONDRI Investigators.”

  • Baycrest Hospital

    Dr. Angela Troyer is program director of Neuropsychology and Cognitive Health, Professional Practice Chief of Psychology, and Practicum Supervisor, Baycrest Health Sciences; Assistant Professor, University of Toronto; and Adjunct Faculty Member, York University. She obtained her PhD in neuropsychology from the University of Victoria and completed a postdoctoral research fellowship at the Rotman Research Institute of Baycrest Health Sciences. 

    Her primary clinical interest is neuropsychological evaluation of mild cognitive impairment (MCI) and dementia, and memory intervention in normal aging and MCI. Her research interests focus on memory changes in normal aging, MCI, and dementia; effectiveness of memory interventions; and relationship between executive functions and memory.

    Angela Troyer Photo
  • University Health Network

    Dr. Anthony Lang’s current appointments include Director, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital; Director in Division of Neurology, University of Toronto; Lily Safra Chair in Movement Disorders, University Health Network; and Jack Clark Chair, University of Toronto Centre for Research in Neurodegenerative Disease (CRND).

    He trained in internal medicine and neurology at the University of Toronto and completed postgraduate training in movement disorders at Kings College Hospital and the Institute of Psychiatry, England. His research includes clinical studies of poorly recognized neurological disorders, clinical trials of new therapeutic modalities and collaborative basic and clinical studies involving molecular biology, neurophysiology, neuropsychology, and imaging.

    Anthony Lang Photo
  • University Health Network

    Dr. Barry Greenberg is the Director of Strategy for Toronto Dementia Research Alliance and Director, Neuroscience Drug Discovery and Development, University Health Network. He obtained his PhD in genetics from the University of North Carolina. He’s been directly involved in Alzheimer’s disease research and drug discovery since 1985.

    Barry Greenberg Photo
  • University of Waterloo

    Dr. Bill McIlroy is the Chair and Professor, Department of Kinesiology, University of Waterloo. He obtained his PhD in neuroscience from the University of Guelph. His research focuses on understanding how the brain and other parts of the central nervous system control movements of the body and translating this knowledge to help individuals improve their recovery after a neurological injury such as a stroke.

    Bill McIlroy Photo
  • University Health Network

    Dr. Carmela Tartaglia is an Assistant Professor, University of Toronto and maintains a cognitive/behavioral clinic within the University Health Network Memory Clinic. She received her BSc (physiology and minor neuroscience) and MD from McGill University, completed her residency at Western University and did three years of clinical/research fellowship in cognitive/behavioral neurology at the University of California, San Francisco Memory and Aging Center.

    Her clinical and research interests lie in searching for biological markers for diagnosing neurodegenerative diseases including chronic traumatic encephalopathy and frontotemporal lobar degeneration. She uses imaging, pathology and genetics to better understand the pathological substrates that cause cognitive, behavioral and motoric dysfunction in neurodegenerative diseases. The ultimate goal of her research program is to provide early, pathology-specific treatments to her patients.

    Carmela Tartaglia Photo
  • University of Waterloo

    Dr. Chris Hudson is a Professor and Associate Director, Research, School of Optometry, University of Waterloo; Professor, Department of Ophthalmology and Vision Science, University of Toronto; and Senior Scientist,  Toronto Western Research Institute.

    He completed his PhD at the University of Aston, UK and post-doctoral studies at the University of Manchester, UK. Prior to moving to Canada in 2000, he was a Reader in Clinical Vision Science at the School of Biomedical Sciences, University of Ulster, Northern Ireland, UK. His research aims to improve the patho-physiological understanding and clinical monitoring of retinal disease and also to evaluate new techniques in a clinical setting to provide sensitive, objective outcome measures of both retinal and systemic disease.

    Chris Hudson Photo
  • Ottawa Hospital

    Dr. David Grimes is the Associate Scientist, Neuroscience Program, Ottawa Hospital Research Institute; Chair and Chief, Neurology/Medicine, University of Ottawa; Associate Professor, Neurology/Medicine, University of Ottawa; Director, Parkinson's Disease and Movement Disorders Clinic, Ottawa Hospital; and Co-Director, Parkinson Research Consortium, University of Ottawa.

    He obtained his MD and completed his residency in neurology at the University of Ottawa. His major clinical interests are in the diagnosis and treatment of a wide variety of movement disorders with an emphasis on Parkinson's disease and dystonia. His research focus is in movement disorders with a focus on Parkinson's disease.

    David Grimes Photo
  • St. Michael’s Hospital

    Dr. David Munoz is the Adjunct Scientist, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital; Professor, Laboratory Medicine and Pathobiology, University of Toronto; and Head, Division of Pathology, St. Michael's Hospital. He completed his MD at the University of Navarra. His research interest is focused on neuropathology, particularly the mechanisms of development and progression of degenerative diseases of the brain, including Alzheimer's disease, the non-Alzheimer dementias, movement disorders, and amyotrophic lateral sclerosis.

    Read more.

    David Munoz Photo
  • Queen’s University

    Dr. Doug Munoz is the Director, Centre for Neuroscience Studies and Professor in Biomedical and Molecular Sciences, Psychology, and Medicine, Queen’s University. He obtained his PhD in neurology and neurosurgery at McGill University followed by a postdoctoral fellowship at McGill University and subsequently the National Eye Institute, National Institutes of Health.

    The main goals of his research are devoted understanding the neural circuitry controlling visual fixation and the generation of saccadic eye movements and using our knowledge of this circuitry to probe a variety of neurological and psychiatry disorders such as Attention Deficit Hyperactivity Disorder, Parkinson’s disease, Alzheimer’s disease, Tourette’s Syndrome, and amyotrophic lateral sclerosis. He currently holds at Tier 1 Canada Research Chair, is the President of the Canadian Association for Neuroscience and Chair of the Canadian Institute of health Research (CIHR) Institute of Neuroscience, Mental Health and Addiction.

    Doug Munoz Photo
  • St. Joseph’s Health Care

    Dr. Elizabeth Finger is the Associate Professor of Neurology, Western University. She obtained her MD from Cornell University and completed an internship in internal medicine at Massachusetts General Hospital, followed by residency in neurology at Massachusetts General Hospital and Brigham and Women's Hospital in Boston, Massachusetts.

    Her research focuses on understanding the cognitive, neural, and genetic substrates of abnormal decision-making, emotion, and social behavior in frontotemporal dementias and related disorders.

    Elizabeth Finger Photo
  • Western University

    Dr. J.B. Orange’s current affiliations include Professor and Director, School of Communication Sciences and Disorders, Western University; Associate Scientist - Aging, Rehabilitation and Geriatric Care (ARGC), St. Joseph’s Health Care,  Parkwood Hospital and Lawson Health Research Institute; Research Associate, Canadian Centre for Activity and Aging (CCAA); and Member Academic Division of Developmental Disabilities, Department of Psychiatry Schulich School of Medicine & Dentistry. 

    He obtained his PhD at SUNY, Buffalo and completed his postdoctoral studies in Psychiatry at McMaster University. His research focuses on adult neurogenic language and cognitive communication disorders including dementia, aphasia, right hemisphere brain damage, and traumatic brain injury.

    J.B. Orange Photo
  • Sunnybrook Health Sciences Centre

    Dr. Lorne Zinman’s current appointments and affiliations include Associate Professor of Medicine, University of Toronto; Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Staff Neurologist, Director of the ALS Clinic and EMG Laboratory, Sunnybrook Health Sciences Centre; and Chair of the Canadian Amyotrophic Lateral Sclerosis (ALS) Research Network (CALS).

    He received his MD from the University of Calgary and FRCPC in neurology and MSc in clinical epidemiology from the University of Toronto. His main research aim is to better characterize the clinical, electrophysiological and pathological ALS phenotypes along with conducting translational clinical trials.

    Lorne Zinman Photo
  • St. Joseph’s Health Care

    Dr. Manuel Montero-Odasso is the Associate Professor of Medicine, Epidemiology and Biostatistics, Western University and  Internist and Geriatrician, St. Joseph's Health Care London Parkwood Site, London Health Sciences Centre. He completed his MD and PhD at University of Buenos Aires and postdoctoral fellowship at McGill University. His areas of research are the relationship between cognition and mobility in the elderly, gait as an early predictor of frailty and dementia and falls prevention in older people with cognitive impairment.

    Manuel Montero-Odasso Photo
  • Sunnybrook Health Sciences Centre

    Dr. Mario Masellis’s current appointments and affiliations include Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Assistant Professor, Neurology, University of Toronto; Research Scientist, Neurogenetics, Centre for Addiction and Mental Health; Clinician-scientist, Neurology, Department of Medicine, Sunnybrook Health Sciences Centre; and Director, Movement Disorders Clinic, Department of Medicine, Sunnybrook. 

    He obtained his MD and PhD in clinical neurosciences from the University of Toronto. His current research focus is on the characterization of the genetics, neuropsychological, neuroimaging, and pathological features of the atypical neurodegenerative dementias. He’s also studying the pharmacogenomics of cholinesterase inhibitors in Parkinson’s disease dementia and dementia with Lewy bodies and anti-parkinsonian medications in Parkinson’s disease. 

    Mario Masellis Photo
  • St. Joseph’s Health Care

    Dr. Michael Borrie’s current positions and appointments include Professor, Department of Medicine, Division of Geriatric Medicine, Western University; Head, Department of Geriatric Medicine, Parkwood Hospital; Medical Director, Aging Brain and Memory Clinic, Parkwood Hospital; Medical Director, Dementia Special Care Unit, Western Counties Wing, Parkwood Hospital; Program Director, Southwestern Ontario Regional Geriatric Program; Chair, Protocol Review and Selection Committee, Consortium of Canadian Centres for Clinical Cognitive Research (C5R); and Director, Geriatric Clinical Trials Group, Lawson Research Institute, Parkwood Hospital.

    He obtained his MD from the University of Otago, New Zealand. His research interests include predictors of conversion from mild cognitive impairment to Alzheimer’s disease, including sensitive neuroimaging techniques, and the clinical evaluation of new treatments for Alzheimer’s disease, geriatric rehabilitation and falls in the elderly.

    Michael Borrie Photo
  • Western University

    Dr. Michael J. Strong is Dean of the Schulich School of Medicine & Dentistry and Distinguished University Professor, Western University and Scientist, Robarts Research Institute. He served from 2000 to 2010 as the Chief of Neurology and Co-chair of the Department of Clinical Neurological Sciences, London Health Sciences Centre and Western University. He also served as Co-chair of the Canadian Amyotrophic Lateral Sclerosis (ALS) Research Consortium and is a former member of the Board of Directors of the ALS Society of Canada.

    He undertook his undergraduate training in biochemistry and medicine at Queen's University, neurology training at Western University, and postgraduate training at the Laboratory of Central Nervous System Studies, National Institutes of Health, Bethesda, Maryland. His clinical research focuses on understanding the natural history of ALS (Lou Gehrig’s disease), and in particular the occurrence of “non-motor” manifestations of the disease.

    Michael J. Strong Photo
  • Baycrest Hospital

    Dr. Morris Freedman’s current appointments include Head, Division of Neurology, and Scientist, Rotman Research Institute, Baycrest Centre for Geriatric Care; Professor, Faculty of Medicine (Neurology), University of Toronto; and Executive Medical Director Centre for Memory and Neurotherapeutics, Baycrest. His research is aimed at improving the understanding of the mechanisms underlying cognitive impairment due to Alzheimer’s disease and frontotemporal dementia. A major focus is on the study of social cognition in these disorders and on the development of cognitive assessment procedures in dementia.

    Morris Freedman Photo
  • Western University        

    Dr. Paula McLaughlin's current appointments and affiliations include Clinical Neuropsychologist, ONDRI, Western University. She obtained her PhD in clinical psychology at York University, internship in clinical neuropsychology at Emory University – School of Medicine, and postdoctoral fellowship in clinical neuropsychology at the University of California, Los Angeles. Her research focuses on attention, memory, and executive processing, as well as compensatory methods for cognitive decline in healthy aging and individuals with neurodegenerative conditions.

    * Dr. Paula McLaughlin is on maternity leave until April 2017

    Paula McLaughlin Photo
  • Sunnybrook Health Sciences Centre

    Dr. Rick Swartz completed his MD and PhD training and neurology residency at the University of Toronto. His appointments and affiliations include Stroke Neurologist, Sunnybrook Health Science Centre; Assistant Professor, Division of Neurology, Department of Medicine, University of Toronto; directing the Sunnybrook Stroke Research Unit; Medical Director, NE-GTA Regional Stroke Network; and Director, University of Toronto Stroke Program.  

    As a clinician-scientist, his clinical specialty is stroke neurology, with a focus on stroke in the young, stroke in pregnancy, intracranial vascular diseases, and the functional consequences of stroke including vascular cognitive impairment. His research focuses on improving functional impairment in stroke – from hyperacute clinical trials to long-term complications, with a focus on intracranial vascular diseases including both small vessel disease and the cognitive impact of stroke and neuroimaging biomarkers of intracranial arterial disease.

    He developed and validated a rapid, feasible screen for three important post-stroke complications (Depression, Obstructive Sleep Apnea and Cognitive impairment (DOC)). He's the principal investigator of a multi-center CIHR-funded study screening thousands of stroke clinic patients for DOC conditions to identify people at high risk of long-term adverse outcomes (recurrent stroke, MI, institutionalization and death). 

    Rick Swartz Photo
  • Western University

    Dr. Rob Bartha is a Scientist, Robarts Research Institute and Assistant Professor, Department of Diagnostic Radiology and Nuclear Medicine, Western University. He completed his PhD in medical biophysics at Western University. His research is focused on the development of high-field magnetic resonance imaging (MRI) and spectroscopy techniques for early diagnosis of disease and monitoring of treatment response. A major goal is to validate new imaging biomarkers of disease progression and build novel MRI tracers that highlight pathological aspects of a disease process.

    Rob Bartha Photo
  • Western University

    Dr. Rob Hegele is an endocrinologist with an interest in genetics and vascular disease risk. He’s a Scientist, Western University and the Director of the Blackburn Cardiovascular Genetics Lab and London Regional Genomics Centre. He obtained his MD at the University of Toronto with specialty training in internal medicine and endocrinology and followed with postdoctoral training at Rockefeller University and Howard Hughes Medical Institute.

    Rob Hegele Photo
  • Sunnybrook Health Sciences Centre

    Dr. Sandra Black’s current appointments and affiliations include Director of and Senior Scientist in the Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; Deborah Ivy Christian Brill Chair in Neurology, Department of Medicine, University of Toronto and Sunnybrook Health Sciences Centre; Site leader, Heart and Stroke Foundation Canadian Partnership for Stroke Recovery; Executive director of Toronto Dementia Research Alliance; and Director, LC Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre; and Affiliate Scientist, Rotman Research Institute, Baycrest and Toronto Rehabilitation Institute.

    She obtained her MD and neurology training at the University of Toronto, postdoctoral training at Western University, and MA equivalent in the history and philosophy of science at Oxford University. Her research has focused on differential diagnosis and treatment of the dementias, cognitive sequelae of stroke and stroke recovery and cerebral small vessel disease. She's led clinical trials in dementia and exploits neuroimaging biomarkers to elucidate brain-behaviour relationships in stroke and dementia, including development of customized brain imaging pipelines to quantify atrophy, focal stroke and white matter disease.

    Photography credit: Curtis Lantinga for Sunnybrook Research Institute.​

    Sandra Black Photo
  • Sunnybrook Health Sciences Centre

    Dr. Sean Symons current appointments include Associate Professor of Medical Imaging and Otolaryngology - Head and Neck Surgery, University of Toronto; Deputy Radiologist-in-Chief and Head Division of Neuroradiology, Sunnybrook Health Sciences Centre; and Affiliate Scientist, Sunnybrook Research Institute. He completed his MD at the University of Toronto, residency in diagnostic radiology at Queen’s University, and fellowship in neuroradiology at Harvard University and Massachusetts General Hospital. His research focuses are neurodegenerative, head and neck imaging for cancer and otology, stroke imaging, brain tumour imaging, and neurovascular imaging by computed tomography and magnetic resonance.

    Sean Symons Photo
  • Baycrest Hospital

    Dr. Stephen Strother is a Senior Scientist, Rotman Research Institute, Baycrest and Professor, Department of Medical Biophysics, University of Toronto. He obtained his PhD at the Montreal Neurological Institute, McGill University. His research is directed at developing and testing a set of optimal experimental planning and analysis tools for neuroimaging researchers that are coupled with his own, and others', state-of-the-art neuroimaging research databases.

    Read more.

    Stephen Strother Photo